Format

Send to

Choose Destination
Vaccine. 2008 Dec 2;26(51):6495-6. doi: 10.1016/j.vaccine.2008.09.062.

Severe thrombocytopenia after hepatitis B vaccine in an infant from Turkey.

Author information

1
Fatih University, Faculty of Medicine, Department of Pediatric Hematology, HoĊŸdere Caddesi No: 145, 06540 Y. Ayranci, Ankara, Turkey. azizp4@yahoo.com.tr

Abstract

Recombinant hepatitis B vaccine has been used widely in the world since 1991. The side effects of hepatitis B vaccine are seen rarely. In this paper, we present clinical and laboratory progress of an infant who gets severe thrombocytopenia after the second dosage hepatitis B vaccine. Our case is different from other cases because our patient is very young, the number of platelet is the lowest in the literature, and intravenous immunoglobulin (IVIG) are immunoglobulin (IVIG) are used in the treatment. Although it is a severe thrombocytopenia, the patient has recovered without any bleeding.

PMID:
18926870
DOI:
10.1016/j.vaccine.2008.09.062
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center